Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.45 |
| ▸ | PRKDC | P78527 | 4/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17547775 | 0.94 | ALOX5 (0.48) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL17547772 | 0.92 | ALOX5 (0.46) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL15179939 | 0.91 | ALOX5 (0.42) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL16883028 | 0.89 | ALOX5 (0.55) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL16883071 | 0.89 | ALOX5 (0.55) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL16883210 | 0.89 | ALOX5 (0.49) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL16883142 | 0.88 | ALOX5 (0.53) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL16883191 | 0.88 | ALOX5 (0.53) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL17734660 | 0.88 | ALOX5 (0.46) | ALOX5PRKDCGGPS1PTGES2TNKS | |
| SCHEMBL16883235 | 0.87 | ALOX5 (0.48) | ALOX5PRKDCGGPS1PTGES2TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10985325-B2 | Aromatic amine derivative, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2021-04-20 | — | — | US | disclosed |
| EP-3312167-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-20150263292-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-17 | — | — | US | disclosed |
| US-20150263292-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-17 | — | — | US | disclosed |
| EP-2891653-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | Idemitsu Kosan Co., Ltd (JP) | 2015-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150263292-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | RER1, H1-2, NAP1L1 | ALOX5 2443/4885PRKDC 4736/4885GGPS1 4411/4885 |
| US-10985325-B2 | Aromatic amine derivative, and organic electroluminescent element using same | RER1, H1-2, NAP1L1 | ALOX5 2443/4885PRKDC 4736/4885GGPS1 4411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.